Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/10/842   
Active ingredient: Nimorazole
Indication: Treatment of squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Sponsor: Azanta A/S
Gearhalsvej 1, 2500 Valby, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2011 Orphan designation EMA/OD/093/10 (2011)1308 of 23/02/2011
05/08/2016 Change of name and/or address of sponsor